The goal of the symposium was to highlight how recent fundamental advances in neuroimmunology and mast cell biology may provide a new future paradigm for drug discovery and development.
We were honored to have Dr. Brian Kim of Washington University chairing the symposium and Dr. Xinzhong Dong, HHMI Investigator and of Johns Hopkins School of Medicine, Dr. Michelle E. Conroy of Harvard University, and Dr. Nicolas Gaudenzio of Inserm, each present on their work in mast cell biology and skin neuroimmunology, and its translational implications.
Advancing Innovation in Dermatology Inc. is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.
Donations are tax-deductible as allowed by law. | Privacy Policy
© 2024 Advancing Innovation in Dermatology Inc.. All Rights Reserved.